Dupilumab Reduces COPD Exacerbations, Shows Promise for Personalized Treatment: Study Finds Medha Baranwal29 April 2025 8:00 PM ISTUSA: A pooled analysis of two phase 3, randomized, double-blind, placebo-controlled trials has demonstrated the effectiveness of dupilumab as an...
Type 2 Inflammation Linked to Increased risk of Surgery for otitis media effusion: Study Dr Riya Dave23 Jan 2025 8:15 PM ISTType 2 inflammation (T2I) was highly predictive of the likelihood to have a surgery performed due to otitis media with effusion (OME). These findings...
Dupilumab lowers exacerbations in COPD and type 2 inflammation and improves lung function: NEJM Dr. Kamal Kant Kohli25 May 2024 8:15 AM ISTChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug-dupilumab-that showed rapid and sustained...
Type 2 inflammation may accelerate lung function decline in individuals with chronic airway diseases: Study Medha Baranwal19 Jan 2024 6:00 PM ISTDenmark: A recent study has shown that type 2 inflammation indicated by increased blood eosinophils (BE) and a fraction of exhaled nitric oxide (FeNO)...
Dupilumab improves clinical outcomes in patients having chronic rhinosinusitis with nasal polyps Dr. Kamal Kant Kohli26 July 2023 9:30 AM ISTUSA: A recent study published in Allergy & Asthma Proceedings on the efficacy of the human monoclonal antibody Dupilumab in patients with chronic...
Dupilumab lessens disease severity in COPD patients with type 2 inflammation Dr. Kamal Kant Kohli28 Jun 2023 8:00 PM ISTChronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the...
Sterilization of milk may reduce risk of milk-induced eosinophilic oesophagitis Dr. Kamal Kant Kohli2 Sept 2022 7:00 AM ISTSPAIN: Most patients with a history of eosinophilic esophagitis caused by milk proteins did not develop eosinophilic esophagitis (EoE) after consuming...
Dupilumab significantly improves itch and hives in chronic spontaneous urticaria patients: Study Hina Zahid5 Aug 2021 9:00 AM ISTUSA: Adding Dupixent (dupilumab) to standard-of-care antihistamines significantly reduced itch and hives in patients with moderate-to-severe chronic...
